Conference Coverage

VIDEO: Childhood obesity, particularly severe obesity, is not declining


 

AT THE PAS ANNUAL MEETING

References

BALTIMORE – Rates of obesity, particularly severe obesity, in children have not decreased since 1999, despite what recent studies may say, according to a study presented at the annual meeting of the Pediatric Academic Societies.

“Overall, there is no evidence of a decrease in obesity in any of our age groups,” said Asheley C. Skinner, Ph.D., of Duke University in Durham, N.C., adding that “we see a sort of consistent, ongoing increase up through 2014 for severe obesity and regular class I obesity for all of our age groups.”

In a video interview, Dr. Skinner discussed the findings of her study, in which data from the National Health and Nutrition Examination Survey (NHANES) from the years 1999-2014 were examined to determine obesity in children aged 2-19 years. A combination of body mass index (BMI) and “a percentage of the 95th percentile” of weight across three age groups – 2-5 years, 6-11 years, and 12-19 years – was used to classify children with class I, class II, or class III (severe) obesity.

Dr. Skinner did not report any relevant financial disclosures.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

dchitnis@frontlinemedcom.com

Recommended Reading

FDA: CT scans safe for patients with electronic medical devices
MDedge Cardiology
Prepsychosis links with elevated metabolic syndrome
MDedge Cardiology
VIDEO: HOPE-3 trial supports broader role for statins in primary prevention
MDedge Cardiology
VIDEO: New ACC consensus guidance addresses nonstatin therapies
MDedge Cardiology
FDA adds safety warnings to certain type 2 diabetes medications
MDedge Cardiology
Ticagrelor cuts post-MI events in diabetes patients
MDedge Cardiology
New analysis bolsters metformin as first line in type 2 diabetes
MDedge Cardiology
STAMPEDE: Metabolic surgery bests medical therapy long term
MDedge Cardiology
No rise in serious HF seen in patients taking saxagliptin or sitagliptin
MDedge Cardiology
Sitagliptin does not reduce liver fat in NAFLD
MDedge Cardiology